These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9225677)

  • 41. Some observations on the cardiotoxic and drug interaction profiles of second generation antihistamines as measured in the guinea pig.
    Roberts DJ; Llenas J
    Arzneimittelforschung; 1996 Aug; 46(8):832-3. PubMed ID: 9125289
    [No Abstract]   [Full Text] [Related]  

  • 42. Potential interaction between terfenadine and macrolide antibiotics.
    Cortese LM; Bjornson DC
    Clin Pharm; 1992 Aug; 11(8):675. PubMed ID: 1511540
    [No Abstract]   [Full Text] [Related]  

  • 43. Loratadine blockade of K(+) channels in human heart: comparison with terfenadine under physiological conditions.
    Crumb WJ
    J Pharmacol Exp Ther; 2000 Jan; 292(1):261-4. PubMed ID: 10604956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 'Allergies' article needs updating.
    Bevill TV
    J Am Osteopath Assoc; 1998 Apr; 98(4):200-1. PubMed ID: 9594481
    [No Abstract]   [Full Text] [Related]  

  • 45. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers.
    Piñeyro-López A; Pineyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez Silva M; Wacksman N; Lujàn Rangel R; de Lago A; Trejo D; Gonzàlez-de la Parra M; Namur S
    Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. More questions than answers: antihistamines' link to cancer.
    Robinson A
    CMAJ; 1994 Sep; 151(6):797-801. PubMed ID: 7916264
    [No Abstract]   [Full Text] [Related]  

  • 47. The guinea pig model for assessing cardiotoxic proclivities of second generation antihistamines.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Aug; 46(8):834-7. PubMed ID: 9125290
    [No Abstract]   [Full Text] [Related]  

  • 48. Antihistamine- and decongestant-induced performance decrements.
    Meltzer EO
    J Occup Med; 1990 Apr; 32(4):327-34. PubMed ID: 1970834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Possible interactions with terfenadine or astemizole.
    Zechnich AD; Hedges JR; Eiselt-Proteau D; Haxby D
    West J Med; 1994 Apr; 160(4):321-5. PubMed ID: 8023479
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Terfenadine therapy: can we justify the risks?
    Rangno R
    CMAJ; 1997 Jul; 157(1):37-8. PubMed ID: 9220940
    [No Abstract]   [Full Text] [Related]  

  • 51. Nonsedating antihistamines should be preferred over sedating antihistamines in patients who drive.
    Hennessy S; Strom BL
    Ann Intern Med; 2000 Mar; 132(5):405-7. PubMed ID: 10691592
    [No Abstract]   [Full Text] [Related]  

  • 52. Adverse drug interactions clinically important for the dermatologist.
    Andersen WK; Feingold DS
    Arch Dermatol; 1995 Apr; 131(4):468-73. PubMed ID: 7726592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Current hazardous drug interactions].
    Neuvonen P
    Duodecim; 1993; 109(20):1833-9. PubMed ID: 7737006
    [No Abstract]   [Full Text] [Related]  

  • 54. [Projection of new antihistamines].
    Eseverri J
    Allergol Immunopathol (Madr); 2000; 28(3):143-52. PubMed ID: 10867385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dangers of non-sedating antihistamines.
    Himmel MH; Honig PK; Worobec AS
    Lancet; 1997 Jul; 350(9070):69; author reply 69-70. PubMed ID: 9217741
    [No Abstract]   [Full Text] [Related]  

  • 56. New insights into the second generation antihistamines.
    Walsh GM; Annunziato L; Frossard N; Knol K; Levander S; Nicolas JM; Taglialatela M; Tharp MD; Tillement JP; Timmerman H
    Drugs; 2001; 61(2):207-36. PubMed ID: 11270939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What to watch for with antihistamines.
    Rosenberg JM; Kirschenbaum HL
    RN; 1981 May; 44(5):70-2. PubMed ID: 6111838
    [No Abstract]   [Full Text] [Related]  

  • 58. Interactions of the H1 antihistamines.
    Bartra J; Valero AL; del Cuvillo A; Dávila I; Jáuregui I; Montoro J; Mullol J; Sastre J
    J Investig Allergol Clin Immunol; 2006; 16 Suppl 1():29-36. PubMed ID: 17357375
    [No Abstract]   [Full Text] [Related]  

  • 59. The metabolism of antihistamines and drug interactions: the role of cytochrome P450 enzymes.
    Renwick AG
    Clin Exp Allergy; 1999 Jul; 29 Suppl 3():116-24. PubMed ID: 10444225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse drug interactions in dental practice: interactions involving antibiotics. Part II of a series.
    Hersh EV
    J Am Dent Assoc; 1999 Feb; 130(2):236-51. PubMed ID: 10036847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.